Company · founded 2017
Eclipse Bioinnovations (United States)
San Diego, United States · eclipsebio.com
- Citations, last 5 years
- 163
- Works, last 5 years
- 10
- h-index
- 15
- Scientists listed
- 2
- Grants since 2016
- 7
Grants received
2024 · research · R44
eMOA: A Multi-Omic Service for Mechanism of Action Determination in Drug Screening
Alexander A Shishkin · Eclipse Bioinnovations (United States) · funded by National Institutes of Health
2024–2026 · research · R44
eMOA: A Multi-Omic Service for Mechanism of Action Determination in Drug Screening
Alexander A Shishkin · Eclipse Bioinnovations (United States) · funded by National Institutes of Health
2019–2023 · research · R44
Development of chimeric read amplification into a robust method for profiling targets of specific microRNAs and global amplification of all microRNA:mRNA pairings transcriptome-wide
Alexander A Shishkin · Eclipse Bioinnovations (United States) · funded by National Institutes of Health
2019–2020 · research · R43
Unambiguous transcriptome-wide identification of microRNA:mRNA interactions through enhanced chimeric read amplification
Alexander A Shishkin · Eclipse Bioinnovations (United States) · funded by National Institutes of Health
2019–2023 · research · R44
Development of chimeric read amplification into a robust method for profiling targets of specific microRNAs and global amplification of all microRNA:mRNA pairings transcriptome-wide
Alexander A Shishkin · Eclipse Bioinnovations (United States) · funded by National Institutes of Health
2017–2019 · research · R44
A robust kit, standards, and software for identifying RNA binding protein targets
Alexander A Shishkin · Eclipse Bioinnovations (United States) · funded by National Institutes of Health
2017–2019 · research · R44
A robust kit, standards, and software for identifying RNA binding protein targets
Alexander A Shishkin · Eclipse Bioinnovations (United States) · funded by National Institutes of Health